“financing” Archives

in
Entry Author Date Location
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
AbCellera Raises $105M to Advance Antibody Discovery Operations 05/27/20 Seattle
Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development 05/26/20 San Francisco
Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments 05/26/20 San Diego
With $30M, Octant Launches Synthetic Bio Search for Multi-Target Drugs 05/20/20 San Francisco
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Pipeline 05/14/20 New York
QurAlis Hauls In $42M to Move New ALS Therapies Into Human Testing 05/13/20 Boston
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
At Rome Therapeutics, Kapeller Aims to Turn “Junk” Into New Drugs 04/28/20 Boston
Erasca Lands $200M Mega-Round to Move Cancer Programs to the Clinic 04/27/20 San Diego
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More 04/24/20 National
ORIC Pharma Gets $120M in IPO to Advance Drug-Resistant Cancer Therapies 04/24/20 San Francisco
Unlearn Adds $12M for “Digital Twins” That Accelerate Clinical Trials 04/20/20 San Francisco
RDMD Lands $14M to Expand Reach of Rare Disease Research Platform 04/16/20 San Francisco
Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal 04/08/20 San Francisco
Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests 04/08/20 Boston
VenBio Partners Bags $394M to Back More Medicine-Making Biotechs 04/03/20 Boston
Flagship Adds $1.1B for New Meds, More AI, & “Health Security” 04/02/20 National
Aspen Neuro Adds $70M to Test Parkinson’s Cell Therapy in the Clinic 04/01/20 San Diego
Aptinyx Moves Ahead With PTSD Therapy Study, Pauses 3 Other Trials 03/31/20 National
Forge Inks Roche Deal For Antibiotic Aimed at Drug-Resistant Infections 03/26/20 San Diego
Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown 03/23/20 National
Keros Outlines IPO Plans Amid Markets Rocked by Coronavirus Pandemic 03/23/20 Boston
Eureka Partners With Lyell to Tackle Tricky Solid Tumor Cell Therapies 03/20/20 San Francisco
How San Diego Biotech Leaders Are Adapting to Coronavirus Concerns 03/19/20 San Diego
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund 03/11/20 Europe
Silverback Therapeutics Adds $79M to Test HER2+ Tumor-Targeting Drug 03/11/20 Seattle
Culture Biosciences Adds $15M for New Software, Bioreactor Expansion 03/05/20 San Francisco
Amunix Raises $73M to Bring Safer T Cell Engagers to Solid Tumors 03/04/20 San Francisco
Page 2 of 80 « previous page · next page »